This could explain in part the lack of benefit, as the CCR2-dependent recruitment of inflammatory monocytes and their subsequent differentiation within the lesioned brain environment into noninflammatory phagocytes has been recently shown to be a key mechanism linking postischemic brain inflammation with repair [3]. This evidence concerns the gene CCR2 and brain inflammatory disease.